Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism
- PMID: 20150576
- PMCID: PMC2853993
- DOI: 10.1210/jc.2009-2106
Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism
Abstract
Context: Serum anti-Müllerian hormone (AMH) levels are significantly elevated in adolescents with polycystic ovary syndrome (PCOS) compared to normal controls. Whether adolescents with oligomenorrhea have elevated AMH levels is unknown.
Objective: This study was performed to assess serum AMH levels in oligomenorrheic (OLIGO) girls without evidence of hyperandrogenism.
Design: This was a prospective study comparing AMH levels in OLIGO, PCOS, and normal control adolescents.
Setting: The study was conducted through four tertiary academic medical centers.
Participants: The study groups were comprised of OLIGO (n = 24), PCOS (n = 153), and normal adolescent girls (n = 39), as well as PCOS (n = 73) and normal adult women (n = 36).
Interventions: In each subject, serum AMH levels were assessed in the early to midfollicular phases for regularly menstruating subjects and on an arbitrary day for OLIGO or PCOS subjects.
Main outcome measure(s): Basal serum AMH levels were assessed among OLIGO, PCOS, and normal girls, in addition to PCOS and normal women.
Results: OLIGO girls had serum AMH levels (5.33 +/- 0.47 ng/ml) that were significantly greater than the normal adolescents (3.05 +/- 0.31 ng/ml) and adults (2.33 +/- 0.22 ng/ml), but similar to values seen in the PCOS adolescents (5.28 +/- 0.26 ng/ml) and adults (6.36 +/- 0.47 ng/ml). Obese adolescents and PCOS women had significantly lower AMH levels compared to lean controls (P < 0.02).
Conclusion: In OLIGO adolescents, elevated serum AMH levels suggest increased antral follicle number similar to that observed in girls with PCOS.
Figures

Similar articles
-
Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):552-557. doi: 10.1111/ajo.12647. Epub 2017 Jun 9. Aust N Z J Obstet Gynaecol. 2017. PMID: 28597496
-
Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.Hum Reprod. 2014 Oct 10;29(10):2317-25. doi: 10.1093/humrep/deu182. Epub 2014 Jul 23. Hum Reprod. 2014. PMID: 25056088 Free PMC article.
-
Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1084-e1095. doi: 10.1210/clinem/dgaa949. J Clin Endocrinol Metab. 2021. PMID: 33351079 Free PMC article.
-
Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.Int J Mol Sci. 2021 Nov 19;22(22):12507. doi: 10.3390/ijms222212507. Int J Mol Sci. 2021. PMID: 34830389 Free PMC article. Review.
-
Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis.Endocr J. 2022 Aug 29;69(8):897-906. doi: 10.1507/endocrj.EJ22-0081. Epub 2022 Jun 8. Endocr J. 2022. PMID: 35675999
Cited by
-
AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women.J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1762-71. doi: 10.1210/clinem/dgaa059. J Clin Endocrinol Metab. 2020. PMID: 32016427 Free PMC article.
-
Establishing an Anti-Müllerian Hormone Cutoff for Diagnosis of Polycystic Ovarian Syndrome in Women of Reproductive Age-Bearing Indian Ethnicity Using the Automated Anti-Müllerian Hormone Assay.J Hum Reprod Sci. 2019 Apr-Jun;12(2):104-113. doi: 10.4103/jhrs.JHRS_149_18. J Hum Reprod Sci. 2019. PMID: 31293324 Free PMC article.
-
Non-Classical Congenital Adrenal Hyperplasia in Childhood.J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):1-7. doi: 10.4274/jcrpe.3378. Epub 2016 Jun 29. J Clin Res Pediatr Endocrinol. 2017. PMID: 27354284 Free PMC article. Review.
-
A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study.Front Endocrinol (Lausanne). 2022 Mar 17;13:821368. doi: 10.3389/fendo.2022.821368. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35370993 Free PMC article.
-
Effect of lncRNA MALAT1 on the Granulosa Cell Proliferation and Pregnancy Outcome in Patients With PCOS.Front Endocrinol (Lausanne). 2022 Apr 27;13:825431. doi: 10.3389/fendo.2022.825431. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35573984 Free PMC article.
References
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25 - PubMed
-
- Yoo RY, Dewan A, Basu R, Newfield R, Gottschalk M, Chang RJ 2006 Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 85:1049–1056 - PubMed
-
- Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D 2003 Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88:5957–5962 - PubMed
-
- Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77–83 - PubMed
-
- Pigny P, Jonard S, Robert Y, Dewailly D 2006 Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91:941–945 - PubMed